AzTrials
AzTrials

Carpal Tunnel Syndrome (CTS)CP syndromeNCT07539480

Pain Neuroscience Education Versus Kinesio Tape on Functional Outcomes in Patients With Carpal Tunnel Syndrome

A study testing group A: pain neuroscience education (PNE) and group B: Patients receive Kinesio Taping in people with Carpal Tunnel Syndrome (CTS), run by Middle East University at 1 site in Egypt.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

Carpal Tunnel Syndrome (CTS) is one of the most common compressive neuropathies of the upper limb, characterized by pain, numbness, and functional impairment due to median nerve compression at the wrist. Read more about this study

Who is it for?
Ages 20 to 50 yearsHealthy volunteers can take part
Conditions the study is for
Carpal Tunnel Syndrome (CTS)
What is being tested?
group A: pain neuroscience education (PNE) and group B: Patients receive Kinesio Taping
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteEgypt
Study dates
15 Jun 2025to 20 Sep 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 50 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • aged 18 to 60 years.
  • Clinically diagnosed unilateral or bilateral carpal tunnel syndrome based on standard diagnostic criteria (e.g., pain, numbness, or tingling in the median nerve distribution), with or without confirmation by nerve conduction studies.
  • Patients with mild to moderate carpal tunnel syndrome, defined by clinical assessment and electrodiagnostic findings.
  • Symptoms present for at least 3 months.
  • Reported wrist or hand pain with functional limitations affecting daily activities.

Who cannot join

  • Severe CTS characterised by significant thenar muscle atrophy or severe nerve conduction impairment.
  • Previous Surgery or Injection:
  • History of carpal tunnel release surgery or corticosteroid injection to the wrist within the past 6 months.
  • Presence of other conditions affecting the upper limb, such as cervical radiculopathy, peripheral neuropathy, rheumatoid arthritis, tendon rupture, or fractures.
  • Known neurological disorders (e.g., stroke, multiple sclerosis) or systemic diseases affecting nerve function (e.g., uncontrolled diabetes mellitus).
  • Skin disease, open wounds, or known allergy to adhesive materials that contraindicate kinesio taping.
Show all 9Show fewer
  • Pregnant women, due to possible changes in fluid retention and nerve compression.
  • Participation in other physical therapy or pain education programmes targeting the upper limbs during the study period.
  • Conditions that limit comprehension of pain neuroscience education material or ability to provide reliable responses to questionnaires.

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Bassam Ahmed Nabil

    October City, Giza Governorate, 6892

Other trials in Egypt

About this study

Official title: Carpal Tunnel Syndrome

Carpal Tunnel Syndrome (CTS) is one of the most common compressive neuropathies of the upper limb, characterized by pain, numbness, and functional impairment due to median nerve compression at the wrist. Its prevalence is estimated at approximately 4.9%, with higher incidence in populations exposed to repetitive hand movements. The resulting sensory disturbances, grip weakness, and functional limitations significantly affect daily activities and quality of life.

Conservative management remains the first line of treatment for mild to moderate CTS, with therapeutic approaches traditionally including splinting, exercise therapy, nerve mobilization, and patient education. Recent interest has grown around Pain Neuroscience Education (PNE)-an educational strategy that reframes patients' understanding of pain by emphasizing the role of the central nervous system, cognitive factors, and neurophysiological processes. Studies have shown that PNE, particularly when combined with exercise or standard rehabilitation, can reduce symptom severity, improve functional outcomes, and help patients better manage chronic pain by reducing fear and catastrophizing. However, the existing literature notes that research on PNE for CTS is still limited, with some trials suggesting positive outcomes but calling for more high-quality evidence.

In parallel, Kinesio Taping (KT) has gained popularity as a noninvasive intervention believed to enhance circulation, provide proprioceptive input, and support soft tissue mobility. Evidence from randomized controlled trials shows that KT can improve grip strength, reduce pain intensity, enhance sensory conduction velocity, and improve functional status as measured by validated clinical tools such as the Boston Carpal Tunnel Questionnaire. These findings suggest that KT may serve as an effective supplementary therapy in the conservative management of CTS

Read the detailed description

Objective: The purpose of this study was to compare between pain neuroscience education and Kinesio tape on functional outcomes in patients with carpal tunnel syndrome Methods: This study involved 60 patients with carpal tunnel syndrome, consisting of 30 females and 20 males, ranging in age from 20 to 50 years. All participants were allocated into two groups: Group (A) patients with pain neuroscience education, Group (B) patients Kinesio tape

Being tested
group A: pain neuroscience education (PNE), group B: Patients receive Kinesio Taping
Keywords
Kinesio tape, carpal tunnel syndrome
Medical subject headings
Carpal Tunnel Syndrome

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • group A: pain neuroscience education (PNE)Other

    1- Education on neurobiology and neurophysiology of pain 2- How beliefs and behaviours influence pain 3- Central sensitization and pain amplification 4- Use of metaphors, visuals, and interactive discussion the frequency of the session 1- 1 session/week, 30-40 minutes 2- Duration: 6 weeks 3- Delivered by a trained physiotherapist

  • group B: Patients receive Kinesio TapingOther

    KT Application Technique 1- Elastic tape placed along flexor retinaculum and median nerve pathway 2- Tension: 10-15% 3- Reapplied twice weekly 4- Duration: 6 weeks

Study groups in NCT07539480
Study groupRoleWhat they receive
group A: pain neuroscience education (PNE)ExperimentalPNE Components
Receives: Other: group A: pain neuroscience education (PNE)
group B: Patients receive Kinesio TapingExperimentalKT Application Technique
Receives: Other: group B: Patients receive Kinesio Taping

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Numeric Pain Rating Scale (NPRS)

    self-reported pain intensity scale ranging from 0 (no pain) to 10 (worst imaginable pain), assessing average hand pain over the past week.

    Measured: 8 weeks

  2. Boston Carpal Tunnel Questionnaire

    The BCTQ is a tool that assesses difficulty in performing daily activities of the hand such as writing, gripping and lifting objects It consists of eight items, each scored from 1 (no difficulty) to 5 (unable to perform activity).

    Higher scores indicate greater functional disability.

    Measured: 8 months

  3. Jamar Hand-Held Dynamometer (kg)

    Assess the maximum voluntary grip strength of the affected hand. Three trials are recorded, and the mean value is used for analysis.

    Measured: 8 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Apr 2026
  2. Study start15 Jun 2025
  3. Primary completion20 Sep 2027 (estimated)
  4. Study completion20 Sep 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
60 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07539480
Sponsor's protocol ID
2730
Acronym
CP syndrome
Status last verified
Apr 2026
First submitted
13 Apr 2026
Last updated
20 Apr 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing group A: pain neuroscience education (PNE) and group B: Patients receive Kinesio Taping in people with Carpal Tunnel Syndrome (CTS), run by Middle East University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 20 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Numeric Pain Rating Scale (NPRS) (time frame: 8 weeks). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Apr 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in